Taking into account test results showing a significant exceedance of the specification limit for impurity B content, the risk to human health from leaving these medicinal product batches on the market is real and probable. Potential effects: toxicity, adverse reactions, therapeutic complications.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use Symibace tablets from the specified batches. Check the batch number on the packaging and, if you have the product, return it to the pharmacy or consult a doctor.
The Symibace batches 28C012A (2.5 mg) and 14S012A (5 mg) were withdrawn from the market nationwide and their placing on the market was prohibited, with the decision given immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related